The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary edema, noncardiogenic (NCPE)
Publications
Severe cardiopulmonary complications of ketamine: Acute pulmonary Edema in a cardiac patient.
Oxford medical case reports. 2025;2025(8):omaf063
Characteristics and circumstances of death related to the self-administration of ketamine.
Addiction (Abingdon, England). 2021;116(2):339-345
Ketamine and pulmonary oedema-report of two cases.
Indian journal of anaesthesia. 2009;53(4):486-8
Acute pulmonary edema after diazepam-ketamine in a dog.
Veterinary anaesthesia and analgesia. 2007;34(5):371-6
Fulminant pulmonary edema after intramuscular ketamine.
Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2000;47(9):894-6
Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse.
Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1993;40(2):160-4